Erasca (ERAS) Short Interest Ratio & Short Volume $2.87 +0.15 (+5.51%) (As of 11/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Erasca Short Interest DataErasca (ERAS) has a short interest of 33.70 million shares, representing 19.21% of the float (the number of shares available for trading by the public). This marks a -0.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 17.8, indicating that it would take 17.8 days of the average trading volume of 1.62 million shares to cover all short positions.Current Short Interest33,700,000 sharesPrevious Short Interest33,710,000 sharesChange Vs. Previous Month-0.03%Dollar Volume Sold Short$94.70 millionShort Interest Ratio17.8 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares282,504,000 sharesFloat Size175,390,000 sharesShort Percent of Float19.21%Today's Trading Volume1,637,275 sharesAverage Trading Volume1,622,529 sharesToday's Volume Vs. Average101% Short Selling Erasca? Sign up to receive the latest short interest report for Erasca and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartERAS Short Interest Over TimeERAS Days to Cover Over TimeERAS Percentage of Float Shorted Over Time Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Erasca Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202433,700,000 shares $94.70 million 0.0%19.2%17.8 $2.81 9/30/202433,710,000 shares $92.03 million +24.7%19.2%15.7 $2.73 9/15/202427,030,000 shares $80.28 million +9.0%15.4%11 $2.97 8/31/202424,810,000 shares $71.70 million +5.9%14.9%12 $2.89 8/15/202423,420,000 shares $63.47 million +5.2%14.1%10.2 $2.71 7/31/202422,260,000 shares $70.12 million +2.1%13.4%9 $3.15 Get the Latest News and Ratings for ERAS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Erasca and its competitors with MarketBeat's FREE daily newsletter. 7/15/202421,810,000 shares $67.17 million +9.0%13.1%9.5 $3.08 6/30/202420,010,000 shares $47.22 million +30.7%12.0%9.9 $2.36 6/15/202415,310,000 shares $33.22 million +8.7%9.2%9.5 $2.17 5/31/202414,080,000 shares $35.48 million +31.2%7.9%9.5 $2.52 5/15/202410,730,000 shares $20.28 million +2.1%6.6%7.6 $1.89 4/30/202410,510,000 shares $21.13 million +10.9%10.2%13.5 $2.01 4/15/20249,480,000 shares $18.96 million +6.9%10.6%12.1 $2.00 3/31/20248,870,000 shares $18.27 million -1.7%9.9%11 $2.06 3/15/20249,020,000 shares $19.30 million -8.9%10.1%11.2 $2.14 2/29/20249,900,000 shares $23.56 million -3.6%11.1%8.4 $2.38 2/15/202410,270,000 shares $18.38 million +0.5%11.5%8.3 $1.79 1/31/202410,220,000 shares $17.07 million -1.0%11.0%9.3 $1.67 1/15/202410,320,000 shares $19.92 million +7.2%11.2%9.3 $1.93 12/31/20239,630,000 shares $20.51 million -12.4%10.4%8.4 $2.13 12/15/202310,990,000 shares $20.55 million +21.4%11.9%9.6 $1.87 11/30/20239,050,000 shares $15.39 million +3.8%9.8%8.8 $1.70 11/15/20238,720,000 shares $20.23 million +10.8%9.3%14.5 $2.32 10/31/20237,870,000 shares $18.18 million +7.1%8.4%12.4 $2.31 10/15/20237,350,000 shares $17.20 million -0.3%7.9%11.7 $2.34 9/30/20237,370,000 shares $14.52 million -12.6%8.0%13.3 $1.97 9/15/20238,430,000 shares $21.75 million -5.5%9.1%16.6 $2.58 8/31/20238,920,000 shares $23.10 million +1.1%9.7%15.8 $2.59 8/15/20238,820,000 shares $22.45 million -17.0%8.4%14 $2.55 7/31/202310,630,000 shares $28.06 million -1.5%11.6%17.1 $2.64 7/15/202310,790,000 shares $28.38 million -0.6%12.7%16.6 $2.63 6/30/202310,850,000 shares $29.95 million +11.2%13.1%15.3 $2.76 6/15/20239,760,000 shares $27.04 million -4.5%11.8%11.7 $2.77 5/31/202310,220,000 shares $27.70 million -1.2%12.4%11.5 $2.71 5/15/202310,340,000 shares $30.61 million -9.2%12.5%11.2 $2.96 4/30/202311,390,000 shares $31.44 million -0.9%13.8%11.8 $2.76 4/15/202311,490,000 shares $33.55 million +1.0%13.9%11 $2.92 3/31/202311,380,000 shares $34.25 million +12.0%13.8%10.3 $3.01 3/15/202310,160,000 shares $32.41 million +18.7%12.3%8.9 $3.19 2/28/20238,560,000 shares $30.82 million +9.2%11.3%7.2 $3.60626 winning trades out of 647… (Ad)Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trader has done over the past 8 years—closing 647 trades, with an unbelievable 97% win rate. Now, for the first time, he's breaking his silence and revealing his personal technique for success.Click here to watch our exclusive interview and uncover his personal technique 2/15/20237,840,000 shares $30.03 million -0.1%10.3%7 $3.83 1/31/20237,850,000 shares $31.40 million -2.6%11.3%7 $4.00 1/15/20238,060,000 shares $33.53 million -22.9%11.6%7.5 $4.16 12/30/202210,460,000 shares $45.08 million -0.5%13.9%10.8 $4.31 12/15/202210,510,000 shares $50.13 million -27.3%17.3%11.8 $4.77 11/30/202214,460,000 shares $109.17 million -9.5%21.8%22 $7.55 11/15/202215,970,000 shares $130.47 million -4.0%24.1%22.6 $8.17 10/31/202216,640,000 shares $135.95 million -5.0%25.8%26.1 $8.17 10/15/202217,520,000 shares $125.27 million -4.2%27.1%28.8 $7.15 9/30/202218,290,000 shares $142.66 million +10.9%28.3%34.4 $7.80 9/15/202216,490,000 shares $144.29 million +4.7%25.6%32.1 $8.75 8/31/202215,750,000 shares $142.07 million +4.3%24.5%38.7 $9.02 8/15/202215,100,000 shares $161.27 million -1.4%23.5%42 $10.68 7/31/202215,310,000 shares $115.44 million -3.5%23.8%38.9 $7.54 7/15/202215,860,000 shares $105.47 million -1.3%24.7%37.9 $6.65 6/30/202216,070,000 shares $89.51 million +4.1%25.0%35 $5.57 6/15/202215,440,000 shares $74.42 million +5.2%24.0%30.8 $4.82 5/31/202214,680,000 shares $79.57 million +3.8%22.8%21.8 $5.42 5/15/202214,140,000 shares $82.01 million +5.2%22.0%20.7 $5.80 4/30/202213,440,000 shares $97.84 million +1.2%20.9%19.6 $7.28 4/15/202213,280,000 shares $114.61 million +7.7%20.7%17.4 $8.63 3/31/202212,330,000 shares $106.04 million +6.0%19.3%15.1 $8.60 3/15/202211,630,000 shares $124.09 million +7.0%18.2%14.1 $10.67 2/28/202210,870,000 shares $134.79 million +4.3%17.0%16.7 $12.40 2/15/202210,420,000 shares $129.62 million +9.8%16.1%16.7 $12.44 1/31/20229,490,000 shares $112.46 million +18.3%14.3%16.7 $11.85 1/15/20228,020,000 shares $103.78 million +8.8%12.0%16.3 $12.94 12/31/20217,370,000 shares $114.82 million +14.4%11.0%19.8 $15.58 12/15/20216,440,000 shares $87.91 million +16.5%9.6%20 $13.65 11/30/20215,530,000 shares $78.36 million +1.3%8.3%16.3 $14.17 11/15/20215,460,000 shares $103.52 million +20.0%8.2%16.4 $18.96 10/29/20214,550,000 shares $90.00 million +23.6%6.6%12.1 $19.78 10/15/20213,680,000 shares $65.50 million +18.3%5.3%9.6 $17.80 9/30/20213,110,000 shares $65.99 million +31.2%4.5%6.3 $21.22 9/15/20212,370,000 shares $49.86 million +15.6%3.4%4.5 $21.04 8/31/20212,050,000 shares $49.02 million +72.3%3.1%4.1 $23.91 8/13/20211,190,000 shares $23.90 million No Change1.9%2.1 $20.08 ERAS Short Interest - Frequently Asked Questions What is Erasca's current short interest? Short interest is the volume of Erasca shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 33,700,000 shares of ERAS short. 19.21% of Erasca's shares are currently sold short. Learn More on Erasca's current short interest. What is a good short interest ratio for Erasca? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ERAS shares currently have a short interest ratio of 18.0. Learn More on Erasca's short interest ratio. What is a good short interest percentage for Erasca? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.21% of Erasca's floating shares are currently sold short. Is Erasca's short interest increasing or decreasing? Erasca saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 33,700,000 shares, a decline of 0.0% from the previous total of 33,710,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Erasca's float size? Erasca currently has issued a total of 282,504,000 shares. Some of Erasca's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Erasca currently has a public float of 175,390,000 shares. How does Erasca's short interest compare to its competitors? 19.21% of Erasca's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Erasca: Verve Therapeutics, Inc. (27.92%), Nuvation Bio Inc. (4.39%), Lyell Immunopharma, Inc. (9.43%), Black Diamond Therapeutics, Inc. (12.95%), Relay Therapeutics, Inc. (8.86%), Recursion Pharmaceuticals, Inc. (26.21%), Arvinas, Inc. (13.56%), Wave Life Sciences Ltd. (3.92%), Tectonic Therapeutic (4.28%), Ocular Therapeutix, Inc. (8.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Erasca stock? Short selling ERAS is an investing strategy that aims to generate trading profit from Erasca as its price is falling. ERAS shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Erasca? A short squeeze for Erasca occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ERAS, which in turn drives the price of the stock up even further. How often is Erasca's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ERAS, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies VERV Short Squeeze NUVB Short Squeeze LYEL Short Squeeze BDTX Short Squeeze RLAY Short Squeeze RXRX Short Squeeze ARVN Short Squeeze WVE Short Squeeze TECX Short Squeeze OCUL Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ERAS) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Erasca, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Erasca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
